ARQT Arcutis Biotherapeutics Inc tops Q4 2025 EPS estimates on 91 percent year over year revenue growth shares slip 203 percent Why elf Beauty ELF looks solid from every angle Smart Money Exits 20260508 DWTX Dogwood Therapeutics Inc posts far narrower Q4 2025 loss than consensus estimates yet shares dip 447 today Transcat TRNS Q1 earnings miss EPS estimates by 235 despite revenue growth of 73 yearoveryear IMUX Immunic EPS beats estimates by 27 despite zero revenue yet stock slides on pipeline concerns The inflation impact visible in National NSA results Q1 2026 EPS Exceeds Expectations F Ford Motor delivers blowout quarter with EPS soaring 245 percent above expectations shares climb Amer Power AEP Financial Health Q4 2025 EPS Exceeds Expectations Savara SVRA Stock Pricing Efficiency Review Q4 2025 EPS Misses Estimates JOYY Inc JOYY revenue declines 51 percent YoY EPS misses estimates by 43 percent stock falls modestly OCUL Ocular Therapeutix Inc tops Q4 2025 EPS estimates shares gain slightly even as quarterly revenue declines year over year Paysafe PSFE Stock Deep Dive Buying Pressure 20260418